Beranda › Stroke › Minnesota › Minneapolis
Uji klinis Stroke di Minneapolis, MN
5 studi untuk Stroke mencari peserta di lokasi sekitar Minneapolis (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Continuous Dual Aspiration Technique With Zoom System for Stroke
Menerima pesertaStudi observasional
- Allina Health, Minneapolis
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Menerima pesertaFase 2/3
- Abbott Northwestern Hospital, Minneapolis
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
Menerima peserta
- Minneapolis Heart Institute Foundation - Abbott Northwestern Hospital, Minneapolis
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging
Menerima pesertaStudi observasional
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Feasibility of a Remotely Delivered Step Count Intervention in Chronic Stroke
Menerima peserta
- University of Minnesota, Minneapolis
Uji klinis Stroke di kota lain
- Chicago, IL34 studi
- New York City, NY30 studi
- Boston, MA30 studi
- Houston, TX24 studi
- Baltimore, MD22 studi
- Pittsburgh, PA22 studi
- Atlanta, GA20 studi
- Charleston, SC18 studi
- Washington, DC18 studi
- Philadelphia, PA18 studi
- Cleveland, OH16 studi
- Jacksonville, FL16 studi
Studi lain di Minneapolis
- Kanker Payudara27 studi
- Kanker Paru Non-Sel Kecil26 studi
- Kanker Ovarium24 studi
- Kanker Prostat23 studi
- Kanker (semua jenis)22 studi
- Gagal Jantung21 studi
- Kanker Paru20 studi
- Leukemia Mieloid Akut20 studi
- Kanker Kolorektal19 studi
- Kanker Endometrium18 studi
- Penyakit Parkinson17 studi
- Penyakit Kardiovaskular15 studi
Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.